Evidence map›Paper›PMID 41079562›Full record

ArticleSchizophrenia research. Cognition2026

Neurocognitive function in schizophrenia spectrum disorders: A 20-year prospective study of a community sample.

Christine Mohn, Anna-Karin Olsson, Maivor Olsson-Tall, Fredrik Hjärthag, Iris van Dijk Härd, Lars Helldin

Abstract read
In one paragraph

Article in Schizophrenia research. Cognition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christine MohnNational Centre for Suicide Research and Prevention, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Anna-Karin OlssonDepartment of Psychiatry, NU Health Care Hospital, Trollhättan, Västra Götaland Region, Sweden.
Maivor Olsson-TallInstitute of Health Sciences, University West, Trollhättan, Sweden.
Fredrik HjärthagDepartment of Psychology, Karlstad University, Karlstad, Sweden.
Iris van Dijk HärdDepartment of Psychiatry, NU Health Care Hospital, Trollhättan, Västra Götaland Region, Sweden.
Lars HelldinDepartment of Psychiatry, NU Health Care Hospital, Trollhättan, Västra Götaland Region, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Longitudinal studies of neurocognition in schizophrenia spectrum disorders (SSD) usually follow relatively young first-episode patients across several years. Comparatively little is known about the neurocognitive trajectory of samples also consisting of older patients. This is a 20-year follow-up study of participants who performed the baseline assessment at different ages and utilizes data from the Swedish Clinical Long-Term Psychosis Study (CLIPS). At baseline, 61 SSD patients were included and available for clinical assessment after 20 years. Of these, 28 performed neurocognitive assessment at both baseline and 20 years later. The test results from this group were used for this study. After 20 years, the participants exhibited significantly worsening cognitive flexibility, verbal learning, verbal retention memory, and verbal intellectual function compared to baseline. All the statistically significant differences from baseline to follow-up had large effect sizes. The other cognitive domains showed no statistically significant changes from baseline for either group. We conclude that although the overall picture was one of neurocognitive stability across 20 years, our participants showed signs of accelerated ageing in the verbal domain specifically.

Indexed as

Longitudinal studyMemoryNeurocognitionProspective studyPsychosisSchizophrenia

Identifiers

PMID41079562
PMCPMC12512163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.